Product Information

EZETIMIBE 10 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0718 per EA under NDC 31722062890. Its NADAC has been published 163 times since Oct 11, 2023.

FDA first approved this application on Jul 26, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EZETIMIBE 10 MG TABLET

EZETIMIBE
$0.0718per EA

Strength

10 mg/1

NDC

31722062890

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

EZETIMIBE

Approval Type

Generic (ANDA)

FDA Application

ANDA210859

FDA Approved

7/26/2022

TE Code

AB

On Market Since

7/26/2022

Pharmacological Classes

Decreased Cholesterol Absorption
Dietary Cholesterol Absorption Inhibitor

Price Statistics

The NADAC for EZETIMIBE 10 MG TABLET has been published 163 times since Oct 11, 2023, and over the history we have for it it has declined 11.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0718 per EA
All-time high$0.1021 (Apr 10, 2024)
All-time low$0.0667 (Sep 23, 2026)
52-week high$0.0756
52-week low$0.0667
Median price$0.0754
Average price$0.0774
Largest weekly change+22.7% (Jun 19, 2024)
Weeks tracked163
Tracking sinceOct 11, 2023

Price History

1W

+2.0%

1M

+7.7%

3M

+6.5%

6M

+0.5%

1Y

+4.6%

3Y

-18.0%

5Y

N/A

All

-11.3%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of EZETIMIBE 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE 10 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0718 per EA (NDC 31722062890), effective Nov 18, 2026.

How has the price of EZETIMIBE 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for EZETIMIBE 10 MG TABLET has declined 11.3%. It has been tracked across 163 weekly CMS publications since Oct 11, 2023.

What are the highest and lowest recorded NADAC prices for EZETIMIBE 10 MG TABLET?

Since Oct 11, 2023, the NADAC for EZETIMIBE 10 MG TABLET has ranged from a low of $0.0667 (Sep 23, 2026) to a high of $0.1021 (Apr 10, 2024), with a median of $0.0754 per EA.

Are there cheaper alternatives to EZETIMIBE 10 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EZETIMIBE 10 MG TABLET, is $0.0715 per EA — about 1% below EZETIMIBE 10 MG TABLET.

Who manufactures EZETIMIBE 10 MG TABLET?

EZETIMIBE 10 MG TABLET (NDC 31722062890) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.